VTRS - Viatris goes ex-dividend today
2023-08-23 13:35:09 ET
More on Viatris
- Viatris Emerges As Challenger In Lucrative Anti-Obesity Drugs Market
- Viatris: Turning Point For Cheap Pharma Stock
- Viatris Q2 2023 Earnings Review: Buy, Sell, Or Hold After Mixed Results?
- Viatris Inc. ( VTRS ) Q2 2023 Earnings Call Transcript
- S&P changes outlook on Viatris to negative
- Viatris multiple sclerosis therapy accepted for FDA review
- Viatris posts first topline beat in over a year as Q2 revenue improves
- Viatris hopes for Q2 earnings beats amid negative YTD return
- Seeking Alpha’s Quant Rating on Viatris
- Earnings data for Viatris
- Dividend scorecard for Viatris
For further details see:
Viatris goes ex-dividend today